Belen Perez Solans, PhD

Photo of Belen Perez Solans, PhD
Title(s)Postdoctoral Scholar, Bioengineering
SchoolSchool of Pharmacy
Address1700 4th Street, #501C
San Francisco CA 94158
ORCID ORCID Icon0000-0003-4621-5480 Additional info
vCardDownload vCard

    Collapse Bibliographic 
    Collapse publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Pharmacokinetics and Dose Optimization of Ethambutol in Children on First-line Antituberculosis Therapy: An Individual Patient Data Meta-Analysis. J Infect Dis. 2026 Mar 30. Chung TK, Yang E, Shin M, Solans BP, Zhou X, Hwang S, Yoon MC, Purohit D, Yang D, Mouksassi S, Béranger A, Bekker A, Kwara A, Panjasawatwong N, Savic RM. PMID: 41906661.
      View in: PubMed   Mentions:    Fields:    
    2. Efficacy of isoniazid in paediatric tuberculosis: an individual participant data meta-analysis. Eur Respir J. 2026 Mar; 67(3). Béranger A, Solans BP, Miyakawa R, McIlleron H, Tarning J, Shah I, Aruldhas BW, Mathew BS, Kwara A, Peloquin CA, Mukherjee A, Lodha R, Denti P, Capparelli EV, Kiser JJ, Bekker A, Chabala C, Choo L, Turkova A, Gafar F, Ruslami R, Nataprawira HM, Heysell SK, Thomas TA, Velpandian T, Day JN, Bang ND, Dooley K, Savic RM. PMID: 41412716.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Dolutegravir concentrations in children receiving 3-month weekly isoniazid and rifapentine (3HP) for tuberculosis prevention. Microbiol Spectr. 2026 Feb 03; 14(2):e0330325. Madzime RJ, van der Laan L, du Toit S, Barnabas S, Courtney I, Brown NE, Savic R, Solans BP, Dixon MG, Tsirizani L, Denti P, Boyd R, Hesseling AC, TBTC Study 35 team. PMID: 41504451; PMCID: PMC12889135.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Deriving Dosages for Levofloxacin Tuberculosis Preventive Treatment for Young People Exposed to Rifampicin-Resistant Tuberculosis. J Infect Dis. 2025 Nov 14; 232(5):1178-1186. Solans BP, Miyakawa R, Shin M, Hesseling AC, White Y, Masini T, Kanchar A, Falzon D, Savic RM. PMID: 40794705; PMCID: PMC12614971.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Pharmacokinetics and Safety of Clofazimine in Children With Rifampicin-Resistant Tuberculosis. J Infect Dis. 2025 Jun 02; 231(5):e873-e881. Hughes JA, Solans BP, Garcia-Prats AJ, Draper HR, Schaaf HS, Nielsen JC, Nortier E, Courtney I, Palmer M, van der Laan L, Savic RM, Hesseling AC. PMID: 39932891; PMCID: PMC12128054.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    6. Simultaneous initiation of dolutegravir-based antiretroviral therapy and once-weekly rifapentine and isoniazid for tuberculosis prevention in antiretroviral-naive people with HIV: an open-label, non-randomised, phase 1/2 trial. Lancet HIV. 2025 Jun; 12(6):e428-e439. Weld ED, Beattie T, Moodley J, Mapendere M, Salles I, Solans BP, Nonyane BAS, Wiesner L, Nielson T, Edward VA, Chihota V, Savic RM, Dooley KE, Chaisson RE, Churchyard GJ, DOLPHIN-TOO Study Team, Unitaid IMPAACT4TB Research Group. PMID: 40349709; PMCID: PMC13374581.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    7. Characteristics of children and adolescents with multidrug-resistant and rifampicin-resistant tuberculosis and their association with treatment outcomes: a systematic review and individual participant data meta-analysis. Lancet Child Adolesc Health. 2025 02; 9(2):100-111. Garcia-Prats AJ, Garcia-Cremades M, Cox V, Kredo T, Dunbar R, Schaaf HS, Seddon JA, Furin J, Achar J, Radke K, Sachs T, Abubakirov A, Ahmed S, Akkerman OW, Al Ani NA, Amanullah F, Ahmad N, Anderson LF, Asfaw M, Bango F, Bauer T, Becerra M, Boeree M, Brinkmann F, Brown R, Brust J, Campbell JR, Carvalho AC, Carvalho I, Cegielski JP, Centis R, Chan ED, Chauhan S, Chiang SS, Chan PC, D'Ambrosio L, Dalcolmo M, Daneilyan N, de Vries G, Draper HR, endTB Study Group, Fairlie L, Francis JR, Franke M, Gegia M, Restrepo CG, Guenther A, Gureva T, Haecker B, Harausz E, Hewison C, Hicks RM, Huerga H, Hughes J, Isaakidis P, Kadri SM, Khan MA, Kotrikadze T, Kuksa L, Lachenal N, Lange C, Lecca L, Lopez-Varela E, Lucena S, Mariandyshev A, Mattoo S, Mendez-Echevarria A, Migliori GB, Mitnick C, Mohr-Holland E, Mulanda W, Murzabakova T, Myrzalieve B, Ndjeka N, Niemann S, Ozere I, Padayatchi N, Parmar M, Parpieva N, Manzur-Ul-Alam M, Rybak N, Sachdeva KS, Salmon K, Santiago-Garcia B, Schaub D, Shah I, Shah S, Shah V, Sharma S, Shim TS, Shin S, Sinha A, Skrahina A, Solanki H, Solans BP, Soriano-Arandes A, Toktogonova A, van der Werf T, Velásquez GE, Williams B, Yim JJ, Savic R, Hesseling A. PMID: 39855750; PMCID: PMC13289721.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    8. Linezolid Pharmacokinetic-Anemia Modeling in Children With Rifampicin-Resistant Tuberculosis. Clin Infect Dis. 2024 12 17; 79(6):1495-1502. Brooks JT, Solans BP, Béranger A, Schaaf HS, van der Laan L, Sharma S, Furin J, Draper HR, Hesseling AC, Garcia-Prats AJ, Savic RM. PMID: 39422476; PMCID: PMC11650862.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    9. Optimizing Lumefantrine Dosing for Young Children in High-Malaria-Burden Countries Using Pharmacokinetic-Pharmacodynamic Simulations. Open Forum Infect Dis. 2024 Nov; 11(11):ofae627. Simeon S, Hughes E, Wallender E, P Solans B, Savic R. PMID: 39544493; PMCID: PMC11561580.
      View in: PubMed   Mentions: 1  
    10. Dose optimization of TBI-223 for enhanced therapeutic benefit compared to linezolid in antituberculosis regimen. Nat Commun. 2024 08 25; 15(1):7311. Strydom N, Ernest JP, Imperial M, Solans BP, Wang Q, Tasneen R, Tyagi S, Soni H, Garcia A, Bigelow K, Gengenbacher M, Zimmerman M, Xie M, Sarathy JP, Yang TJ, Dartois V, Nuermberger EL, Savic RM. PMID: 39181887; PMCID: PMC11344811.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCellsCTClinical Trials
    11. Pharmacokinetic-pharmacodynamic modeling of tuberculosis time to positivity and colony-forming unit to assess the response to dose-ranging linezolid. Antimicrob Agents Chemother. 2024 08 07; 68(8):e0019024. Simeon S, Garcia-Cremades M, Savic R, Solans BP. PMID: 39016594; PMCID: PMC11323931.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCellsCTClinical Trials
    12. Prolonged Opioid Use Is Associated With Poor Pain Alleviation After Orthopaedic Surgery. J Am Acad Orthop Surg. 2024 Jul 01; 32(13):e661-e670. Marmor MT, Hu S, Mahadevan V, Floren A, Solans BP, Savic R. PMID: 38696825.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    13. Pharmacokinetics and Optimal Dosing of Levofloxacin in Children for Drug-Resistant Tuberculosis: An Individual Patient Data Meta-Analysis. Clin Infect Dis. 2024 03 20; 78(3):756-764. White YN, Solans BP, Denti P, van der Laan LE, Schaaf HS, Vonasek B, Malik AA, Draper HR, Hussain H, Hesseling AC, Garcia-Prats AJ, Savic RM. PMID: 38340060; PMCID: PMC10954342.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    14. Pharmacokinetics and cardiac safety of clofazimine in children with rifampicin-resistant tuberculosis. Antimicrob Agents Chemother. 2024 01 10; 68(1):e0079423. Ali AM, P Solans B, Hesseling AC, Winckler J, Schaaf HS, Draper HR, van der Laan L, Hughes J, Fourie B, Nielsen J, Wiesner L, Garcia-Prats AJ, Savic RM. PMID: 38112526; PMCID: PMC10777824.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    Belen's Networks
    Concepts (61)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (7)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-40-gb10dcd06 on PROFILES-PWEB04.

    Copyright © The Regents of the University of California.